CAPTRUST Financial Advisors’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

CAPTRUST Financial Advisors’s Portfolio FNCH Stock Details FNCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-106	Closed	-$9K	–	4447
2022 Q2	$9K	Hold	106	–	–	﹤0.01%	3830
2022 Q1	$16K	Hold	106	–	–	﹤0.01%	3549
2021 Q4	$32K	Sell	106 -5	-5%	-$1.92K	﹤0.01%	2992
2021 Q3	$43K	Hold	111	–	–	﹤0.01%	2684
2021 Q2	$47K	Buy	111 +5	+5%	+$2.16K	﹤0.01%	2554
2021 Q1	$51K	Buy	+106	New	+$54K	﹤0.01%	2420

Other funds holding FNCH

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

AMC

Avenir Management Company New York $43.8M AUM 101.91% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

LSAG

Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return

TRB Advisors New York $146M AUM 3.71% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

CAPTRUST Financial Advisors's FNCH Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Finch Therapeutics Group, Inc. Common Stock (FNCH) in Q3 2022, closing a stake of 106 shares — an estimated $9K sold.

CAPTRUST Financial Advisors first reported a position in FNCH in Q1 2021 and held it in 6 quarters. The position peaked at $51K in Q1 2021. 43 funds tracked by Wall St. Rank hold FNCH as of Q3 2022.

CAPTRUST Financial Advisors reported no remaining Finch Therapeutics Group, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
CAPTRUST Financial Advisors sold 106 Finch Therapeutics Group, Inc. Common Stock shares in Q3 2022, an estimated $9K.
CAPTRUST Financial Advisors first reported a position in Finch Therapeutics Group, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
CAPTRUST Financial Advisors's Finch Therapeutics Group, Inc. Common Stock position peaked at $51K in Q1 2021.
43 funds tracked by Wall St. Rank held Finch Therapeutics Group, Inc. Common Stock as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.